Literature DB >> 7555191

Antithrombotic agents in coronary artery disease.

J A Cairns1, H D Lewis, T W Meade, G C Sutton, P Théroux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7555191     DOI： 10.1378/chest.108.4_supplement.380s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

Review 1.  Is aspirin underused in myocardial infarction?

Authors:  J M Arnau; A Agustí
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

2.  Economic evaluation of enoxaparin sodium versus heparin in unstable angina. A French sub-study of the ESSENCE trial.

Authors:  B Detournay; X Huet; F Fagnani; G Montalescot
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

3.  Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and Design.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

Review 4.  Prevention and treatment of venous thromboembolism.

Authors:  G F Pineo; R D Hull
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

5.  The use of low molecular weight heparin to predict clinical outcome in patients with unstable angina that had undergone percutaneous coronary intervention.

Authors:  Young Joon Hong; Myung Ho Jeong; Seung Hyun Lee; Ok Young Park; Ju Han Kim; Weon Kim; Jay Young Rhew; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Soon Pal Suh; Byoung Hee Ahn; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.